Indo Euro Indchem FY26 Results: Net profit falls 12% to ₹31.9 lakh

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Net profit fell 12% YoY to ₹31.90 lakh for FY26
  • Revenue from operations declined slightly to ₹1,372.80 lakh
  • Finance costs surged to ₹3.08 lakh from ₹0.42 lakh
  • Loans granted jumped to ₹1,210.12 lakh from ₹238.93 lakh
  • Secretarial audit flagged compliance lapses on director loans
powered bylight_fuzz_icon
50140383

*this image is generated using AI for illustrative purposes only.

Indo Euro Indchem reported a decline in net profit for the financial year ended March 31, 2026, driven by higher finance costs and lower other income, despite an improvement in operating margins before depreciation.

The chemical trading company posted a net profit of ₹31.90 lakh for FY26, down from ₹36.23 lakh in the previous year. Revenue from operations remained relatively flat at ₹1,372.80 lakh, compared to ₹1,388.59 lakh in FY25.

Financial Performance

While revenue dipped slightly, the company's core operational efficiency showed marginal improvement. Profit before interest and depreciation rose to ₹49.31 lakh from ₹46.84 lakh in the prior year. However, this gain was offset by a significant increase in finance costs, which jumped to ₹3.08 lakh from ₹0.42 lakh.

Other income also contracted to ₹52.32 lakh from ₹61.39 lakh, primarily due to a drop in interest income and the absence of commission income recorded in the previous year.

Metric FY26 FY25 Change
Revenue from Operations ₹1,372.80 lakh ₹1,388.59 lakh -1.1%
Net Profit After Tax ₹31.90 lakh ₹36.23 lakh -12.0%
Other Income ₹52.32 lakh ₹61.39 lakh -14.8%
Finance Costs ₹3.08 lakh ₹0.42 lakh +633.3%

Balance Sheet Shifts

A notable shift occurred in the company's asset allocation. Loans granted surged to ₹1,210.12 lakh from ₹238.93 lakh, indicating a heavy deployment of surplus funds into interest-bearing loans. Conversely, trade receivables fell sharply to ₹304.84 lakh from ₹1,385.66 lakh, suggesting improved collection efficiency or a change in credit terms.

Cash and cash equivalents decreased to ₹5.43 lakh from ₹13.73 lakh. The current ratio weakened significantly to 0.71 from 1.88, reflecting a tighter liquidity position relative to current liabilities.

Governance and Compliance Issues

The secretarial audit report highlighted several compliance lapses. The company failed to update its website with mandatory disclosures under SEBI Listing Regulations. Additionally, it did not submit intimation regarding newspaper publications to stock exchanges for the quarters ended June 30, 2025, and September 30, 2025.

More critically, the audit noted violations of Section 185(1) of the Companies Act, 2013, regarding loans advanced to entities owned by directors or their relatives. Loans totaling ₹6.15 crore were given to Vishal Enterprises (owned by Director Akshit Lakhani) and ₹4.33 crore to RL Global (owned by a relative of a director). The auditors classified these as loans to directors in substance.

Furthermore, the company paid remuneration exceeding the limits approved by members in January 2023, violating Section 197 of the Companies Act. The Board has acknowledged these issues and committed to corrective measures.

What the Numbers Show

The divergence between rising operating profit before depreciation and falling net profit highlights the impact of non-operational expenses. Finance costs increased seven-fold, while other income declined by nearly 15%. This suggests that while core trading operations stabilized, the bottom line was pressured by higher borrowing costs and reduced ancillary income streams.

Historical Stock Returns for Indo Euro Indchem

1 Day5 Days1 Month6 Months1 Year5 Years
+9.83%+5.23%+6.60%-27.60%-31.44%+20.19%

How will the significant increase in loans granted to related parties impact the company's future liquidity and regulatory standing with SEBI?

What specific corrective measures has the Board proposed to address the violations of Section 185 and Section 197 of the Companies Act, and what are the associated financial penalties?

Given the current ratio dropping to 0.71, what strategies is Indo Euro Indchem employing to strengthen its short-term solvency and manage current liabilities?

Indo Euro Indchem appoints Paresh Shah as whole-time director

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Paresh Shah appointed as Whole-time Director for five years
  • Appointment effective August 27, 2026, pending shareholder approval
  • Akshit Lakhani resigns citing personal commitments
  • Lakhani steps down from Audit Committee and Stakeholders Relationship Committee
powered bylight_fuzz_icon
49376461

*this image is generated using AI for illustrative purposes only.

Indo Euro Indchem has appointed Paresh Shah as Whole-time Director, effective August 27, 2026. The board also accepted the resignation of Akshit Lakhani from the same role.

The appointment follows a recommendation from the Nomination and Remuneration Committee. Shah will serve a five-year term ending August 26, 2031, subject to shareholder approval at the upcoming Annual General Meeting.

Leadership Changes

Akshit Lakhani resigned citing pre-occupation and other personal commitments. His resignation takes effect from the closure of business hours on August 27, 2026.

Consequently, Lakhani ceases to be a Member of the Audit Committee and Chairman of the Stakeholders Relationship Committee.

New Director Profile

Paresh Shah brings expertise in sales, marketing, and business development. The company highlighted his experience in developing markets and driving sustainable revenue growth.

Particulars Details
Appointee Paresh Shah
Role Whole-time Director
Term Five years
Effective Date August 27, 2026
Resigning Director Akshit Lakhani

The company confirmed that Shah is not debarred from holding office by any regulatory authority. There are no inter-se relationships between Shah and other board members.

Historical Stock Returns for Indo Euro Indchem

1 Day5 Days1 Month6 Months1 Year5 Years
+9.83%+5.23%+6.60%-27.60%-31.44%+20.19%

How might Paresh Shah's background in sales and market development influence Indo Euro Indchem's revenue growth strategy over the next five years?

What impact could the leadership transition have on the company's current operational stability and ongoing business development initiatives?

Will shareholders approve Paresh Shah's appointment at the upcoming AGM, and what factors might influence their voting decision?

More News on Indo Euro Indchem

1 Year Returns:-31.44%